Literature DB >> 15383545

The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix.

Jarmo Käpylä1, Juha Jäälinoja, Mira Tulla, Joni Ylöstalo, Liisa Nissinen, Tiina Viitasalo, Piia Vehviläinen, Varpu Marjomäki, Petri Nykvist, Anna-Marja Säämänen, Richard W Farndale, David E Birk, Leena Ala-Kokko, Jyrki Heino.   

Abstract

Collagen IX is the prototype fibril-associated collagen with interruptions in triple helix. In human cartilage it covers collagen fibrils, but its putative cellular receptors have been unknown. The reverse transcription-PCR analysis of human fetal tissues suggested that based on their distribution all four collagen receptor integrins, namely alpha1beta1, alpha2beta1, alpha10beta1, and alpha11beta1, are possible receptors for collagen IX. Furthermore primary chondrocytes and chondrosarcoma cells express the four integrins simultaneously. Chondrosarcoma cells, as well as Chinese hamster ovary cells transfected to express alpha1beta1, alpha2beta1, or alpha10beta1 integrin as their only collagen receptor, showed fast attachment and spreading on human recombinant collagen IX indicating that it is an effective cell adhesion protein. To further study the recognition of collagen IX we produced recombinant alphaI domains in Escherichia coli. For each of the four alphaI domains, collagen IX was among the best collagenous ligands, making collagen IX exceptional compared with all other collagen subtypes tested so far. Rotary shadowing electron microscopy images of both alpha1I- and alpha2I-collagen IX complexes unveiled only one binding site located in the COL3 domain close to the kink between it and the COL2 domain. The recognition of collagen IX by alpha2I was considered to represent a novel mechanism for two reasons. First, collagen IX has no GFOGER motif, and the identified binding region lacks any similar sequences. Second, the alpha2I domain mutations D219R and H258V, which both decreased binding to collagen I and GFOGER, had very different effects on its binding to collagen IX. D219R had no effect, and H258V prevented type IX binding. Thus, our results indicate that collagen IX has unique cell adhesion properties when compared with other collagens, and it provides a novel mechanism for cell adhesion to cartilaginous matrix.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383545     DOI: 10.1074/jbc.M409412200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Structure of collagen receptor integrin α(1)I domain carrying the activating mutation E317A.

Authors:  Matti Lahti; Eva Bligt; Henri Niskanen; Vimal Parkash; Anna-Maria Brandt; Johanna Jokinen; Pekka Patrikainen; Jarmo Käpylä; Jyrki Heino; Tiina A Salminen
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

2.  Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases.

Authors:  Maryline Fresquet; Thomas A Jowitt; Joni Ylöstalo; Paul Coffey; Roger S Meadows; Leena Ala-Kokko; David J Thornton; Michael D Briggs
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

3.  Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis.

Authors:  Guido Veit; Daniela Zwolanek; Beate Eckes; Stephan Niland; Jarmo Käpylä; Manon C Zweers; Akemi Ishada-Yamamoto; Thomas Krieg; Jyrki Heino; Johannes A Eble; Manuel Koch
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 4.  Regulation of corneal stroma extracellular matrix assembly.

Authors:  Shoujun Chen; Michael J Mienaltowski; David E Birk
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

5.  Type IX collagen interacts with fibronectin providing an important molecular bridge in articular cartilage.

Authors:  Philippa Parsons; Sophie J Gilbert; Anne Vaughan-Thomas; David A Sorrell; Rebecca Notman; Mark Bishop; Anthony J Hayes; Deborah J Mason; Victor C Duance
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

6.  Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2).

Authors:  Mitsuhiko Takahashi; Yoshito Matsui; Tomohiro Goto; Gen Nishimura; Shiro Ikegawa; Hirofumi Ohashi; Natsuo Yasui
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

7.  Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms.

Authors:  Kalle H Sipilä; Kati Drushinin; Pekka Rappu; Johanna Jokinen; Tiina A Salminen; Antti M Salo; Jarmo Käpylä; Johanna Myllyharju; Jyrki Heino
Journal:  J Biol Chem       Date:  2018-04-03       Impact factor: 5.157

8.  Trabecular bone deterioration in col9a1+/- mice associated with enlarged osteoclasts adhered to collagen IX-deficient bone.

Authors:  Chiachien Jake Wang; Keisuke Iida; Hiroshi Egusa; Akishige Hokugo; Anahid Jewett; Ichiro Nishimura
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

9.  Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.

Authors:  Chang-Qi Zhu; Svetlana N Popova; Ewan R S Brown; Dalia Barsyte-Lovejoy; Roya Navab; Warren Shih; Ming Li; Ming Lu; Igor Jurisica; Linda Z Penn; Donald Gullberg; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-28       Impact factor: 11.205

Review 10.  Integrins.

Authors:  Malgorzata Barczyk; Sergio Carracedo; Donald Gullberg
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.